vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and EXELIXIS, INC. (EXEL). Click either name above to swap in a different company.
EXELIXIS, INC. is the larger business by last-quarter revenue ($598.7M vs $351.4M, roughly 1.7× APOGEE ENTERPRISES, INC.). EXELIXIS, INC. runs the higher net margin — 40.8% vs 4.7%, a 36.1% gap on every dollar of revenue. On growth, EXELIXIS, INC. posted the faster year-over-year revenue change (5.6% vs 1.6%). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 2.9%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
APOG vs EXEL — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $598.7M |
| Net Profit | $16.6M | $244.5M |
| Gross Margin | 22.4% | 95.6% |
| Operating Margin | 7.3% | 39.3% |
| Net Margin | 4.7% | 40.8% |
| Revenue YoY | 1.6% | 5.6% |
| Net Profit YoY | 568.8% | 74.8% |
| EPS (diluted) | $0.78 | $0.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | $598.7M | ||
| Q4 25 | $348.6M | $597.8M | ||
| Q3 25 | $358.2M | $568.3M | ||
| Q2 25 | $346.6M | $555.4M | ||
| Q1 25 | $345.7M | $566.8M | ||
| Q4 24 | $341.3M | — | ||
| Q3 24 | $342.4M | $539.5M | ||
| Q2 24 | $331.5M | $637.2M |
| Q1 26 | $16.6M | $244.5M | ||
| Q4 25 | $16.5M | $193.6M | ||
| Q3 25 | $23.6M | $184.8M | ||
| Q2 25 | $-2.7M | $159.6M | ||
| Q1 25 | $2.5M | $139.9M | ||
| Q4 24 | $21.0M | — | ||
| Q3 24 | $30.6M | $118.0M | ||
| Q2 24 | $31.0M | $226.1M |
| Q1 26 | 22.4% | 95.6% | ||
| Q4 25 | 23.8% | 96.9% | ||
| Q3 25 | 23.1% | 96.6% | ||
| Q2 25 | 21.7% | 96.5% | ||
| Q1 25 | 21.6% | 96.5% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | 96.8% | ||
| Q2 24 | 29.8% | 97.2% |
| Q1 26 | 7.3% | 39.3% | ||
| Q4 25 | 7.1% | 39.6% | ||
| Q3 25 | 7.5% | 37.6% | ||
| Q2 25 | 2.0% | 33.6% | ||
| Q1 25 | 1.8% | 28.8% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 12.3% | 25.2% | ||
| Q2 24 | 12.5% | 43.3% |
| Q1 26 | 4.7% | 40.8% | ||
| Q4 25 | 4.7% | 32.4% | ||
| Q3 25 | 6.6% | 32.5% | ||
| Q2 25 | -0.8% | 28.7% | ||
| Q1 25 | 0.7% | 24.7% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 8.9% | 21.9% | ||
| Q2 24 | 9.4% | 35.5% |
| Q1 26 | $0.78 | $0.89 | ||
| Q4 25 | $0.77 | $0.69 | ||
| Q3 25 | $1.10 | $0.65 | ||
| Q2 25 | $-0.13 | $0.55 | ||
| Q1 25 | $0.12 | $0.47 | ||
| Q4 24 | $0.96 | — | ||
| Q3 24 | $1.40 | $0.40 | ||
| Q2 24 | $1.41 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $1.1B |
| Total DebtLower is stronger | $232.3M | — |
| Stockholders' EquityBook value | $511.8M | $2.2B |
| Total Assets | $1.1B | $2.8B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | $1.1B | ||
| Q4 25 | $41.3M | $988.5M | ||
| Q3 25 | $39.5M | $791.1M | ||
| Q2 25 | $32.8M | $1.0B | ||
| Q1 25 | $41.4M | $1.1B | ||
| Q4 24 | $43.9M | — | ||
| Q3 24 | $51.0M | $1.2B | ||
| Q2 24 | $30.4M | $1.0B |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $511.8M | $2.2B | ||
| Q4 25 | $512.3M | $2.2B | ||
| Q3 25 | $500.2M | $2.0B | ||
| Q2 25 | $481.8M | $2.1B | ||
| Q1 25 | $487.9M | $2.2B | ||
| Q4 24 | $522.1M | — | ||
| Q3 24 | $506.4M | $2.3B | ||
| Q2 24 | $480.0M | $2.1B |
| Q1 26 | $1.1B | $2.8B | ||
| Q4 25 | $1.1B | $2.8B | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.2B | $2.8B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $917.1M | $3.0B | ||
| Q2 24 | $889.0M | $2.8B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | $333.5M |
| Free Cash FlowOCF − Capex | — | $332.4M |
| FCF MarginFCF / Revenue | — | 55.5% |
| Capex IntensityCapex / Revenue | 7.8% | 0.2% |
| Cash ConversionOCF / Net Profit | 7.37× | 1.36× |
| TTM Free Cash FlowTrailing 4 quarters | — | $875.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | $333.5M | ||
| Q4 25 | $29.3M | $290.3M | ||
| Q3 25 | $57.1M | $49.0M | ||
| Q2 25 | $-19.8M | $211.4M | ||
| Q1 25 | $30.0M | $240.3M | ||
| Q4 24 | $31.0M | — | ||
| Q3 24 | $58.7M | $271.3M | ||
| Q2 24 | $5.5M | $119.5M |
| Q1 26 | — | $332.4M | ||
| Q4 25 | $22.9M | $288.8M | ||
| Q3 25 | $52.4M | $46.2M | ||
| Q2 25 | $-26.9M | $208.5M | ||
| Q1 25 | $19.1M | $236.3M | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | $263.1M | ||
| Q2 24 | $-1.8M | $113.0M |
| Q1 26 | — | 55.5% | ||
| Q4 25 | 6.6% | 48.3% | ||
| Q3 25 | 14.6% | 8.1% | ||
| Q2 25 | -7.8% | 37.5% | ||
| Q1 25 | 5.5% | 41.7% | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | 48.8% | ||
| Q2 24 | -0.5% | 17.7% |
| Q1 26 | 7.8% | 0.2% | ||
| Q4 25 | 1.9% | 0.2% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 2.1% | 0.5% | ||
| Q1 25 | 3.2% | 0.7% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | 1.5% | ||
| Q2 24 | 2.2% | 1.0% |
| Q1 26 | 7.37× | 1.36× | ||
| Q4 25 | 1.77× | 1.50× | ||
| Q3 25 | 2.41× | 0.27× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | 12.08× | 1.72× | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | 2.30× | ||
| Q2 24 | 0.18× | 0.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
EXEL
| Cabometyx | $544.7M | 91% |
| Collaboration | $52.1M | 9% |
| Collaborative Arrangementwith Takeda | $5.9M | 1% |
| Cometriq | $1.8M | 0% |
